Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00287287
Status:
COMPLETED
Last Update Posted:
2020-06-12
First Post:
2006-02-03
Brief Title:
REVLIMID Lenalidomide for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas
Sponsor:
Kenneth Ain
Organization:
University of Kentucky
Organization Data
Organization:
University of Kentucky
Class:
OTHER
Study ID:
05-701-F3R
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kenneth Ain
Lead Sponsor Class:
OTHER
Responsible Party:
Kenneth Ain
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Kentucky
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |